Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 144 participants.
Also called NCT01913847
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 144 participants
- Registry
-
NCT01913847
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01913847. Randomized; triple masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
- Condition
- Pulmonary Hypertension
- Condition
- Systolic Dysfunction
- Intervention (Drug)
- Sildenafil
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct01913847- Content hash
540b6ea0fe3aab3eeabdcd3958b4979b6867d2f5171968316d2d19894590d246